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Background: Inflammation is a response of body tissues to injury or irritation. Small RNAs, such as miR-146a and
miR-499, participate in various processes of tumorigenesis. A recent study indicates that inflammation and abnormal
immune responses may promote malignant progression in cancer development, indicating that inflammation-related
polymorphisms such as miR-146a rs2910164 and miR-499 rs3746444 are crucial. However, studies on the association
of these two polymorphisms with hepatocellular carcinoma (HCC) are inconclusive and inconsistent. We aimed at
accessing the combined result of reported studies and make a more precise estimate of the relationship.
Methods: Meta-analysis was performed on the associations between the miR-146a rs2910164 C > G and miR-499
rs3746444 T > C polymorphisms and hepatocellular carcinoma, using: allele contrast, dominant, and recessive models.
A total of 12 studies(8 on miR-146a rs2910164 and 4 on miR-499 rs3746444) with three populations (Chinese, Korean,
Turkish) were included in this study.
Results: Results show that both allele frequency and genotype distributions of miR-146a rs2910164 polymorphism are
significantly associated with susceptibility to HCC (G versus C: OR = 1.153, 95% CI 1.083–1.228, P < 0.001; GC versus CC:
OR = 1.165, 95% CI 1.054–1.286, P = 0.003; GG versus CC: OR = 1.361, 95% CI 1.192–1.553, P < 0.001; GG/GC versus CC:
OR = 1.213, 95% CI 1.104–1.333, P < 0.001; GG versus GC/CC: OR = 1.210, 95% CI 1.080–1.356, P < 0.001). Our data
suggest that people with G allele have a higher susceptibility to HCC as compared to those with C allele. However,
meta-analysis failed to detect associations between miR-499 rs3746444 and HCC risk under each genetic model
tested. Subgroup analysis showed that Chinese population with CC genotype are more vulnerable to HCC (OR = 2.171,
95% CI = 1.149–4.104, P = 0.017) than those with TT genotype.
Conclusions: We conclude that rs2910164 in miR-146a may confer susceptibility to HCC, especially in the Chinese
population. No significant association was found between miR-499 rs3746444 and HCC, but subgroup study showed
that subjects with CC genotype are more vulnerable to HCC than TT genotype in the Chinese population.Background
Hepatocellular carcinoma (HCC) is one of the most
common malignant tumors and the third most common
cause of cancer-related mortality worldwide [1], espe-
cially in China. The incidence and mortality rates of this
debilitating illness are almost equal due to associated
poor prognosis and high fatality. About 695,900 people
die each year in China from primary carcinoma of the* Correspondence: wmeng@shmu.edu.cn
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reproduction in any medium, provided the orliver, which contributes to almost 45% mortality globally
[2]. Research on the mechanism of cancer, ongoing for
over a century, has so far revealed that infections such
as Hepatitis B and C are major causes of HCC, and en-
vironmental factors such as excessive alcohol intake,
cigarette smoking, and obesity are factors that may in-
crease the risk of HCC [3]. However, a recent study
showed that only a fraction of HBV-infected patients de-
veloped HCC during their lifetime [4], thus implying that
genetic factors may also contribute to carcinogenesis.
Since microRNAs (miRNAs) were first described in
1993, these small, evolutionarily conserved, endogenous,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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http://www.biomedcentral.com/1471-2350/15/92single-stranded, non-coding RNA molecules [5], typic-
ally 20 to 22 nucleotides in length, have been found to
post-transcriptionally function as negative regulators of
gene expression and function [6]. Growing evidence sug-
gests that miRNAs regulate a wide range of biological
processes, including development, cell differentiation, in-
flammation, proliferation, and apoptosis [7], and they
even play a crucial role in initiating human cancers [8].
Therefore, dysregulated miRNAs, which otherwise func-
tion as suppressors of tumors or ontogenesis, may be
responsible for the initiation, progression, and treatment
outcomes of various forms of cancer [9]. Single nucleo-
tide polymorphisms (SNPs) are the most common type
of genetic variations associated with population diversity,
disease susceptibility, and individual response of medi-
cine [10].
Recent studies have demonstrated that inflammation
and abnormal immune responses play an important role
in HCC development. Kazuo Tarao et al. concluded that
inflammation in the background non-cancerous cirrhotic
portion of the liver could evoke malignant progression
in HCC development [11]. Nonsteroidal anti-inflammatory
drugs (NSAIDs) have also been shown to reduce chronic
inflammation and the risk of various forms of cancer [12].
Inflammation related to polymorphism may alter immune
response and thus affect the development of HCC.
miR-146a rs2910164 is located in the stem region op-
posite the mature miR-146a sequence. This C > G poly-
morphism results in a change from C:U pair to G:U
mismatch in the stem structure of miR-146a precursor,
which may have an impact on the development of HCC
[13]. miR-499 rs3746444 is located in the stem region
opposite the mature miR-499 and results in a change
from T:U pair to C:U mismatch in the stem structure of
miR-499 in the miR-499 gene [14]. miR-499 has been
recognized as an ideal biomarker for carcinogenesis due
to its involvement in several biological processes, such
as cellular senescence, apoptosis, inflammation, and im-
mune response, all of which are crucial in the develop-
ment and progression of cancer [14-16].
To date, several groups have reported polymorphisms
such as rs2910164 in miR-146a and miR-499 rs3746444,
which could be biomarkers of susceptibility to HCC
[17]; however, the associations remain controversial and
inconclusive due to the relatively small sample size that
was analyzed. For rs2910164 in miR-146a, Xu et al. [18]
reported that the polymorphism was significantly associ-
ated with the risk of HCC development under a domin-
ant model in the Chinese population, while Zhou et al.
[19] suggested a lack of association between the SNP
and primary liver cancer risk. The lack of power to de-
tect small effects of gene polymorphism on cancer is a
major concern. For miR-499 rs3746444, Kim et al. [20]
failed to identify the association between the SNP andHCC, while Zhou et al. [19] reported that the polymorph-
ism was strongly related to HCC risk. Reports of meta-
analysis from different groups as well show contradicting
opinions on this matter [4,21-23]. Hence, we performed a
meta-analysis of all the eligible studies, hoping to provide
more clarity by systematically summarizing the existing
data.Methods
Identification of eligible studies
We carried out a computer-based search of the most
commonly used database, including PubMed, EMBASE,
Web of Science, Cochrane Central Register of Controlled
Trials, China National Knowledge Infrastructure (CNKI),
China Biological Medicine Database (CBMD) and VIP
(Chinese) to identify all studies examining the relationship
between miR-146a rs2910164, miR-499 rs3746444and
HCC. The following keywords and subject terms were
used for searching: “miR-146a”, “microRNA”, “rs2910164”,
“miR-499”, “rs3746444”, “polymorphism”, “Hepatocellular
Carcinoma”, “liver cancer”, “HCC”,” Liver neoplasm” as
well as combinations, without any restriction on publica-
tion date and language by two independent investigators
(Jiajing Liu and Bo Xie) up to February, 2013. References
of retrieved articles were also scanned. Corresponding
authors of published papers without sufficient data were
contacted by e-mail for more information. The design of
the meta-analysis meets the requiries of moose checklist
(Additional file 1).Criteria for study selection
In order to meet the aim of the meta-analysis, strict cri-
teria were used to identify the relevant published studies:
(i) the study followed a case–control design and the
participants were in both groups voluntarily joined this
study with informed consents; (ii) the study was designed
to evaluate the associations between the SNP miR-146a
rs2910164 or miR-499 rs3746444 polymorphisms and sus-
ceptibility to HCC; (iii) participants recruited from com-
parable populations with similar demographic background
in control and case groups; (iv) a proper diagnosis criteria
of HCC to determine the disease status respectively; (V)
detailed genotype data were provided for the calculation
of odds ratio (OR) and 95% confidence interval (95%CI);
(vi) proper method to determine the genotypes with de-
tailed description of method used; (vii) Hardy-Weinberg
equilibrium (HWE) reached.
We excluded the following: (1) studies that contained
overlapping data, the latest study was included; (2) studies
in which the number of wild genotypes could be ascer-
tained; (3) the manuscript was published as a review or
abstract, not a full original paper. The details are demon-
strated in Figure 1.
247 studies retried from PubMed, EMBASE, Web of Science, 
Cochrane Central Register of Controlled Trials, China National 
Knowledge Infrastructure (CNKI), China Biological Medicine 
Database (CBMD) and VIP(Chinese)
62 duplicate studies
185 potential relevant studies retrieved for detail evaluation
160 excluded after title and abstract review
52 not in human
108 irrelevant to SNPs
25 studies retrieved for full text evaluation
13 excluded after full text review
2 author published 2 related papers
5 reviews or meta-analysis
4 not case-control study on SNPs
2 lack of allele frequencies
12 studies included in meta-analysis
Figure 1 Flow diagram of study identification.
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The Hard-Weinberg Equilibrium (HWE) was evaluated by
the goodness-of-fit chi-square test for the control groups
of each study (significance set at P = 0.05, P < 0.05 was
considered a departure from HWE). If the control groups
were not in HWE, sensitivity analysis or subgroup analysis
was performed to test the robustness of the findings.
The odds ratio (OR) corresponding to the 95% con-
fidence interval (95% CI) was calculated to assess the
strength of association between rs2910164 and rs3746444
polymorphisms and susceptibility to HCC. We performed
a meta-analyses using allele frequency comparison; addi-
tive model; dominant model; and recessive model. The
significance of pooled ORs was determined by Z-test and
P < 0.05 was considered statistically significant. Hetero-
geneity assumption was checked by the chi-square-based
Q-test, and a P > 0.05 indicates a lack of heterogeneity
among studies [24], so the fixed-effects model (the
Mantel-Haenszel method) [25] was applied. Random-
effects model (the DerSimonian and Laird method) [26]are more appropriate when heterogeneity is present.
Sensitivity analysis was carried out by deleting one sin-
gle study each time to examine the influence of individ-
ual data set on the pooled ORs. Modified Egger's linear
regression test and funnel plots are used to detect publica-
tion bias. An asymmetric plot suggests a possible publica-
tion bias and the P <0.05 of Egger’s test was considered
representative of statistically significant publication bias
[27]. All analyses were performed by using the soft-
ware Stata version 11.0 (Stata Corp LP, College Station,
TX, USA). All reported probabilities (P values) were
two-sided.
Results
Description of included studies
A total of 237 articles were identified, based on the
above search criteria, in PubMed, EMBASE, Web of Sci-
ence, Cochrane Central Register of Controlled Trials,
China National Knowledge Infrastructure (CNKI), China
Biological Medicine Database (CBMD), and VIP (Chinese).
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control studies qualified for our meta-analysis [18-20,28-32].
In the study by Wang et al. [29], the authors stratified
their data using three independent subpopulation samples
retrieved from three different provinces and analyzed and
presented them separately. Therefore, we extracted the
data separately and numbered them as Wang-1, Wang-2,
and Wang-3. For the polymorphism of miR-499 rs3746444,
only 4 studies were included in our meta-analysis. Overall,
we identified 8 articles, including 12 samples with 3747
patients and 4779 controls for miR-146a rs2910164 and 4
articles with 746 patients and 1006 controls for miR-499
rs3746444 to evaluate the association of these polymor-
phisms with HCC in Chinese populations. The character-
istics of included studies are summarized in Tables 1 and 2.
All the polymorphisms in the controls of these studies
were found to occur in frequencies consistent with that of
HWE (Tables 1 and 2).
Meta-analysis of the miR-146a rs2910164 polymorphism
and HCC risk
The results of meta-analysis of the miR-146a rs2910164
polymorphism and HCC risk are shown in Table 3. The
meta-analysis was based on 10 independent population
samples with 3747 patients and 4779 controls. Q-test in
all the models showed no significant heterogeneity. There-
fore, all pooled ORs were calculated using fixed-effects
model. Significant association was identified between
miR-146a rs2910164 polymorphism and susceptibility
to HCC in case of all the genetic models (G versus
C: OR = 1.153, 95% CI 1.083–1.228, P < 0.001; GC versus
CC: OR = 1.165, 95% CI 1.054–1.286, P = 0.003; GG versus
CC: OR = 1.361, 95% CI 1.192–1.553, P < 0.001; GG/GC
versus CC: OR = 1.213, 95% CI 1.104–1.333, P < 0.001;
GG versus GC/CC: OR = 1.210, 95% CI 1.080–1.356,
P < 0.001). The forest plots under additive model ofTable 1 Characteristics of studies included in the meta-analys




Zhou 2011 China 669(186/483) PCR-RFLP
Yu 2012 China 200(100/100) PCR-RFLP
Xu 2008 China 983(479/504) PCR-RFLP
Wang-1 2011 China(Jiangsu) 1722(640/1082) MASSARRAY
Wang-2 2011 China(Henan) 583(199/384) MASSARRAY
Wang-3 2011 China(Shanghai) 680(277/403) MASSARRAY
Li 2012 China 1120(560/560) AS-PCR
Zhang 2011 China 1765(925/840) PIRA-PCR
Kim 2012 Korean 360(159/201) PCR-RFLP
Akkiz 2011 Turkey 444(222/222) PCR-RFLP
For miR-146a rs2910164.study between the miR-146a rs2910164 polymorphisms
and HCC risk are presented in Figure 2.Subgroup analysis for miR-146a rs2910164
In addition, a subgroup analysis stratified by study charac-
teristics like population (Chinese and other), genotyping
method (PCR-RFLP and other), sample size, and signifi-
cant association was performed for a better understanding
of the relationship between the SNP and HCC (Table 4).
The study shows a consistently strong association under
additive genetic model, except for other populations
(OR = 0.939, 95% CI 0.752–1.172, P = 0.577) and PCR-
RFLP method (OR = 1.103 95% CI 0.982–1.239, P = 0.097)
subgroups. Though not statistically significant, the PCR-
RFLP method still identified G allele as a risk factor
(OR > 1) in comparison with C allele. However, other
genotyping methods (OR = 1.174, 95% CI = 1.090-1.265,
P < 0.001), such as MassArray, still found an association
between SNP and HCC.Meta-analysis of the miR-499 rs3746444 polymorphism
and HCC risk
The results of meta-analysis based on 4 independent
population samples with 746 patients and 1006 controls
for the miR-499 rs3746444 polymorphism and HCC risk
are shown in Table 5. Q-test in three models (C versus T,
CC versus TT, CC/CT versus TT) showed significant
heterogeneity. Therefore, these three pooled ORs were
calculated using random-effects model. There was no
significant association between HCC and the miR-499
rs3746444 polymorphism under all the genetic models
tested (C versus T: OR = 1.118 95% CI 0.773–1.616,
P = 0.554; CT versus TT: OR = 0.994, 95% CI 0.784–
1.262, P = 0.963; CC versus TT: OR = 1.266, 95% CI
0.596–2.687, P = 0.540; CC/CT versus TT: OR = 1.091is
Case Control х2 HWE
(P value)GG CG CC GG CG CC
33 86 67 71 254 158 3.658195 0.055794
27 45 28 21 46 33 0.443003 0.505677
80 241 158 58 249 197 2.430179 0.119019
122 330 188 166 551 365 3.171700 0.074924
38 103 58 61 185 138 0.005863 0.938967
52 128 97 45 188 170 0.420956 0.51646
124 302 134 92 288 180 1.670302 0.196218
156 450 319 151 386 303 2.086630 0.148594
14 88 57 24 103 74 1.71898 0.189825
137 75 10 144 67 11 0.758665 0.383747
Table 2 Characteristics of studies included in the meta-analysis




Case Control х2 HWE
(P value)CC CT TT CC CT TT
Kim 2012 Korean 399(198/201) PCR-RFLP 3 86 109 7 74 120 1.178699 0.277621
Yu 2012 China 205(105/100) PCR-RFLP 24 45 36 10 36 54 1.147959 0.283977
Zhou 2011 China 716(233/483) PCR-RFLP 4 88 141 12 100 371 2.701215 0.100272
Akkiz 2011 Turkey 432(210/222) PCR-RFLP 90 75 45 82 93 47 4.401451 0.055908
For miR-499 rs3746444.
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OR = 1.265 95% CI 0.924–1.732, P = 0.143).
Subgroup analysis for miR-499 rs3746444
Furthermore, we conducted subgroup analysis including
those on population (Chinese and other) and sample size
(<300 and >300), to analyze characteristic homogeneous
groups in all the genetic models and assess heterogeneity
among the studies (Table 6). The subgroup analysis
under the CC versus TT model showed significant asso-
ciation between miR-499 rs3746444 polymorphism and
HCC risk (OR = 2.171, 95% CI 1.149-4.104, P = 0.017) in
the Chinese population. Subgroup analysis did not show
significant heterogeneity under allele frequency contrast
model, except in the Chinese subgroup. Although meta-
regression analysis failed to identify the source of homo-
geneity due to the limited number of studies, the subgroup
analysis indicated population and sample size as the two
major concerns for the source of heterogeneity.
Publication bias
We used modified Egger’s linear regression test to assess
publication bias of both, the polymorphisms and HCC
risk, under all the genetic models. Symmetrical funnel
plots were obtained in the SNP tested in all the models.
The results showed that no statistically significant small
study or publication bias was present (all P values for bias
of >0.05). The result confirmed the absence of publication
bias in this meta-analysis (Tables 3 and 5).
Sensitivity analysis
In order to assess the robustness of the meta-analysis
results, we carried out a sensitivity analysis. StudiesTable 3 Meta-analysis of the miR-146a rs2910164 polymorph
Genetic model Test of association
OR 95% CI P value
G v C 1.153 1.083-1.228 <0.001
GC v CC 1.165 1.054-1.286 0.003
GG v CC 1.361 1.192-1.553 <0.001
GG/GC v CC 1.213 1.104-1.333 <0.001
GG v GC/CC 1.210 1.080 -1.356 0.001
(F: Fixed-effects model).showed a significant effect on the pooled OR, ex-
cluded to prevent abnormal results or data causing a
deviation from the real association. A single study
was deleted each time to examine the influence of
the individual data set to the pooled ORs.
For rs2910164, not a single study showed significant
effect on the pooled OR. Two independent studies
[28,30] were the main origins of heterogeneity in our
meta-analysis. After excluding those studies, strong asso-
ciation between miR-146a rs2910164 polymorphisms
and HCC risk was still detected in all the models. The
sensitivity analysis indicated that each individual data
had no significant influence on the pooled OR, which
suggests that the result of our meta-analysis is relatively
accurate and robust.
As for rs3746444, one study [19] changed the inter-
study heterogeneity in each model comparison. The sub-
group analysis earlier showed that population is a signifi-
cant source of heterogeneity among studies. After the
deletion of this study, the heterogeneity vanished, while
the association remained insignificant (Table 7).
Discussion
In general, single nucleotide polymorphism (SNP) vari-
ation in miRNA genes has been considered uncommon
owing to high evolutionary conservation across species
[23]. These small, noncoding RNAs, such as miR-146
and miR-499, have been shown to participate in various
processes in tumorigenesis, such as inflammation, cell
cycle regulation, differentiation, apoptosis, and invasion
[33]. Any minor variation in miRNAs is amplified by
hundreds of target genes, and this contributes consider-
ably to the individual’s susceptibility to cancer [6].isms and HCC risk
Test of heterogeneity Publication
bias (P value)Model I2 P value
F 39.9% 0.091 0.816
F 0.0% 0.690 0.874
F 43.2% 0.070 0.990
F 6.7% 0.380 0.927
F 46.1% 0.054 0.846







































Figure 2 Forest plots under additive model of study between the miR-146a rs2910164 polymorphism and HCC risk.
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polymorphism to HCC risk, strong significant associ-
ation can be found across all the genetic models, which
was not in accordance with the previous meta-analysis
reported by Wang et al. [23]. Unfortunately, results were
controversial across the meta-analyses, which may be at
least partly due to the fact that Wang et al. [23] failed to
include all the available studies concerning the asso-
ciation between SNP polymorphism and susceptibility
to HCC. In the subgroup analysis, other genotyping
method, such as MassARRAY, helped find an association
between SNP and HCC (OR = 1.174, 95% CI 1.090–1.265,
P < 0.001). Additionally, PCR-RFLP method (OR = 1.103,
95% CI 0.982–1.239, P = 0.097) shows no significantTable 4 Subgroup-analysis of the miR-146a rs2910164 polym
Subgroup Comparisons Test of association
OR 95% C
Population
Chinese 8 1.174 1.099-
Other 2 0.939 0.752-
Genotyping method
PCR-RFLP 5 1.103 0.982-
Other 5 1.174 1.090-
Sample size
<700 6 1.129 1.010-
>700 4 1.164 1.079-association in the additive model. This may be a result
of many factors. Firstly, the other genotyping method,
namely MassArray, is a relatively new genotyping method
as compared to PCR-RFLP. It has many advantages such
as complete multiple sites in a large sample size. This
relatively updated method may cause differential results.
The traditional method, PCR-RFLP, is a low-cost, golden
standard for genotyping, but cannot accommodate a large
sample size. Secondly, MassARRAY has a relatively high
false-positive rate, which could affect the significance of
the association. Thirdly, the studies with MassARRAY
tend to have a larger sample size, which may make
up for the lack of power to detect a possible small effect
of polymorphism on cancer in small samples of studies.orphisms and HCC risk
Test of heterogeneity
I P value Model I2 P value
1.253 <0.001 F 38.5% 0.123
1.172 0.577 F 0.0% 0.875
1.239 0.097 F 25.8% 0.249
1.265 <0.001 F 54.6% 0.066
1.262 0.033 F 31.3% 0.201
1.256 <0.001 F 60.0% 0.057
Table 5 Meta-analysis of the miR-499 rs3746444 polymorphisms and HCC risk
Genetic model Test of association Test of heterogeneity Publication
bias (P value)OR 95% CI P value Model I2 P value
C v T 1.118 0.773-1.616 0.554 R 77.6% 0.004 0.33
CT v TT 0.994 0.784-1.262 0.963 F 42.5% 0.156 0.382
CC v TT 1.266 0.596-2.687 0.540 R 63.8% 0.040 0.827
CC/CT v TT 1.091 0.726-1.641 0.674 R 68.2% 0.024 0.292
CC v CT/TT 1.265 0.924 -1.732 0.143 F 50.8% 0.107 0.884
(F: Fixed-effects model, R: Random-effects model).
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different results in other population may due to the allele
frequency difference of this SNP between Chinese and
other populations. The G allele frequency in Chinese and
Korean populations was 0.535 (Hap- Map-HCB Genome
browser release #28) and 0.354 (Hap Map-CHB Genome
browser release #28), respectively, while in the Turkish
population, it was 0.800 (Akkiz et al. [31] control data
instead, unable to identify relative data on International
Hap Map Project). The significant difference in this com-
parison supports the finding that population is a major
source of heterogeneity.
The functional C > G SNP rs2910164 in the seed se-
quence of pre-miRNA-146a resulted in mis-pairing ofTable 6 Subgroup-analysis of the miR-499 rs3746444 polymo
Subgroup Comparisons Test of association
OR 95% CI
C versus T
Population OR 95% CI
Chinese 2 1.424 0.730-2.776
Other 2 0.949 0.764-1.179
Sample size
<300 1 2.020 1.333-3.063
>300 3 0.968 0.804-1.165
CC versus TT
Population OR 95% CI
Chinese 2 2.171 1.149-4.104
Other 2 1.021 0.638-1.634
Sample size
<300 1 3.600 1.539-8.421
>300 3 0.998 0.647-1.541
CC/CT versus TT
Population OR 95% CI
Chinese 2 1.325 0.962-1.824
Other 2 0.838 0.611-1.148
Sample size
<300 1 2.087 1.184-3.679
>300 3 0.916 0.716-1.174hairpin structures [34]. The C allele gene displayed
decreased production of mature miR-146a, as compared
to the G allele. The mature miR-146a failed to inhibit
target genes, including IL-1 receptor-associated kinase 1
(IRAK1), TNF receptor-associated factor 6 (TRAF6), and
papillary thyroid carcinoma 1 gene (PTC1) [34]. This re-
sulted in constant activation by the Toll-like receptors
and cytokine receptors and an enhanced inflammatory
response [35]. In general, chronic inflammation is associ-
ated with persistent cell damage and consecutive regener-
ation, potentially leading to changes such as fibrosis and
cirrhosis and eventually HCC [36].
However, we failed to identify any association between
miR-499 rs3746444 polymorphism and HCC risk withrphisms and HCC risk
Test of heterogeneity
P value Model I2 P value
P value Model I2 P value
0.300 R 83.3% 0.015
0.636 F 69.9% 0.068
0.001 NA NA NA
0.733 F 41.8% 0.179
P value Model I2 P value
0.017 F 73.4% 0.053
0.931 F 29.0% 0.235
0.003 NA NA NA
0.994 F 41.8% 0.179
P value Model I2 P value
0.085 F 73.1% 0.054
0.271 F 46.2% 0.173
0.011 NA NA NA
0.489 F 24.8% 0.264
Table 7 Sensitive-analysis of the miR-499 rs3746444 polymorphisms and HCC risk
Genetic model Test of association Test of heterogeneity Publication
bias (P value)OR 95% CI P value Model I2 P value
C v T 0.968 0.804-1.165 0.733 F 41.8% 0.179 0.414
CT v TT 0.907 0.699-1.176 0.462 F 2.9% 0.357 0.868
CC v TT 0.998 0.647-1.541 0.994 F 0.0% 0.479 0.266
CC/CT v TT 0.916 0.716-1.174 0.489 F 24.8% 0.264 0.836
CC v CT/TT 1.070 0.756-1.514 0.704 F 0.0% 0.107 0.216
(F: Fixed-effects model).
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results of previous studies [37]. However, strong hete-
rogenicity was detected under most genetic models. The
subgroup analysis showed that subjects with CC geno-
type in the Chinese population are more vulnerable to
HCC (OR = 2.171, 95% CI 1.149–4.104, P = 0.017) than
those with the TT genotype. This result may indicate
that CC genotype of miR-499 rs3746444 is a risk genotype
and has a higher susceptibility to HCC than any other
genotypes in the Chinese population. The optimal free
energy change from −62.30 kcal/mol for T to −61.90 kcal/
mol for C alleles, suggesting a less-stable secondary struc-
ture for the C allele as compared to the T allele [14]. It has
been observed that genetic variation in mature miRNA
regions could change the conformation of the secondary
structure and thereby directly affect both, binding to tar-
get mRNAs and the miRNA maturation process [38,39].
Although our study failed to identify the association be-
tween miR-499 rs3746444 polymorphism and HCC,
previous reports show an evidence of miRNA contribu-
tion to the development of HCC. Lafferty-Whyte et al.
[15] reported that miR-499 has the potential to regulate
processes involved in the induction of cellular senes-
cence, including telomere shortening, oxidative stress,
oncogene expression, and signaling of DNA damage. In
the sensitivity analysis, one study [19] was identified as a
source of heterogeneity and was excluded from our meta-
analysis. As the heterogeneity was greatly reduced, the
association remained negative with all the genetic models.
In summary, the two miRNAs related to inflammation
that were analyzed in this study may have an important
influence on HCC. Our results suggest that malignant pro-
gression of HCC may be prevented by anti-inflammatory
therapy. Additionally, miRNAs play a major role in the
pathways they regulate, which should be explored further
with respect to autoimmune disease.
Comparisons with other meta-analysis
Although previous meta-analyses have already reviewed
the potential association that we analyzed, our study
improves upon them in the following aspects. Firstly,
most of previous meta-analyses were performed to assesscancer risk [4,21,22,40], irrespective of the tissue origin.
This may affect the reliability of the results due to the
irrevocable heterogeneity brought about by different types
of cancer. Secondly, the only study with hepatocellular
carcinoma and miR-146a [23] failed to detect the associ-
ation between SNP and HCC risk. This may be partly due
to the inability to identify all the studies eligible for ana-
lysis. Post publication of the study by Wang et al. in 2010
[29], two well-designed studies using large sample size of
more ethnic groups were performed by Li et al. [30] and
Kim et al. [20], to further clarify the association. Inte-
restingly, two recently published reports on this topic
show similar results. Zhihua Yin’s [41] study found that
the miR-146a C variant is associated with a decrease in
HCC risk. Yumin Xu’s [42] study suggests that the effect
may be enhanced, especially among Asian males. Our
meta-analysis was specific to HCC and by far contains the
largest number of studies and observations. The reliability
of the results by Zhihua Yin [41] could have been affected
by the irrevocable heterogeneity brought about by differ-
ent types of cancer reviewed. This study did not identify
the sources of heterogeneity and did not simultaneously
sub-group the disease and population. Yumin Xu’s [42]
report in HCC also failed to identify all the eligible studies
(Wang et al. [29] in 2010) and thus excluded almost 2000
samples. Additionally, the report did not describe the
model used to combine the ORs. With regard to miR-499
rs3746444, 4 studies [37,41,43,44] showing no significant
associations between this SNP and overall cancer risk
may have been limited by the heterogeneity introduced by
varying types of tissue. Yumin Xu’s [42] study, specifically
focused on HCC, also failed to find any significant cor-
relation in all the genetic models. We avoided the het-
erogeneity brought about by different types of population;
thus, we may have detected significantly different vul-
nerability between CC and TT genotypes in the Chinese
population.
Limitations
Several limitations of this research should be considered
when interpreting the results due to some limitations of
this meta-analysis. Firstly, our literature searching was
Liu et al. BMC Medical Genetics 2014, 15:92 Page 9 of 10
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guage bias may exist. Secondly, our study only included
three populations (Chinese, Korean and Turkish), so the
result may not be able to extrapolation to other popula-
tions such as African. Thirdly, lack of available data of
many environmental factors including age, HBV/HCV
infection status, gender and alcohol consumption may
limited the possibility of a more comprehensive evaluation
of the association between the SNP and susceptibility to
HCC. Fourthly, no significant association was found be-
tween miR-499 rs3746444 and HCC under every models
may due to the relatively small sample size of those four
studies, and should be interpreted with caution. Lastly,
even to our best knowledge, we can’t discover all grey
literatures.
Conclusions
We performed comprehensive literature search in mul-
tiple databases without limiting publication language and
date. We conducted quantitative data synthesis in allele
frequency, additive model, dominant model and recessive
model. Subgroup analysis was also performed by different
characteristics among studies like region distribution,
genotyping method and sample size under the additive
models. Q-test in all subgroups showed no significant het-
erogeneity. Our meta-analysis, though with limitations,
concludes that there is a strong significant association be-
tween rs2910164 in miR-146a and susceptibility to HCC,
especially in Chinese population. No significant associ-
ation was found between miR-499 rs3746444 and HCC
under every models, but subgroup study shows subjects
with CC genotype in Chinese group are more vulnerable
to HCC (OR = 2.171, 95% CI = 1.149-4.104, P = 0.017) than
those with TT genotype. This result should be interpreted
with caution. Well-designed studies with more ethnic
groups are required to further validate the results.
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